EUVIMEDEUVIMED entdecken
Crossref

Harnessing metabolic dependence-driven antibiotic synergy to eradicate tolerant Pseudomonas aeruginosa

Yuanye Ji, Ping Tuo, Chunyan Ruan, Sijia Zhang, Fajiu Wang, Jia Shen, Peng Zhu

Journal of Antimicrobial Chemotherapy · 03.06.2026 · 81 (7)

DOI: 10.1093/jac/dkag204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 10.06.2026. Verfasst von Yuanye Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Research, Ningbo No.2 Hospital, Ningbo City, Zhejiang Province, China. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents, Pseudomonas Infections. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Zhejiang Provincial Public Welfare Technology Program of China, Natural Science Fund of Ningbo, HwaMei Research Foundation of Ningbo No.2 Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pseudomonas aeruginosa is a major nosocomial pathogen, and its antibiotic tolerance under low-metabolism conditions severely compromises clinical efficacy, presenting a significant therapeutic challenge.

Objectives

A quantitative assessment of the metabolic dependence of clinically relevant antibiotics against P. aeruginosa was conducted, and a novel combination strategy capable of eradicating its low-metabolic populations was developed.

Methods

We established a gradient nutrient model (0%–100% LB) to simulate a continuum of metabolic states. Through linear regression analysis correlating ATP levels with bactericidal efficiency, we developed a Metabolic Dependence Index classification system. Leveraging this system, we designed a Strongly Metabolism-Dependent (SMD) + Weakly Metabolism-Dependent (WMD) synchronous combination strategy, which was subsequently validated using five clinical isolates.

Results

Low-metabolism populations exhibited significantly reduced susceptibility to SMD agents but unaltered tolerance to WMD antibiotics. The SMD + WMD combination achieved enhanced killing of low-metabolism bacteria (>99.999% killing) with a marked dose reduction in vitro. This strategy also improved in vitro clearance efficacy compared to monotherapy. Collectively, our work provides a quantitative framework for targeting metabolic heterogeneity to overcome antibiotic tolerance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaAnti-Bacterial AgentsPseudomonas InfectionsDrug SynergismHumansMicrobial Sensitivity TestsMicrobial Viability

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Centre for Medical Research, Ningbo No.2 Hospital, Ningbo City, Zhejiang Province, China.
  • Department of Thoracic Surgery, Ningbo No.2 Hospital, Ningbo City, Zhejiang Province, China.
  • Department of Hepatopancreatobiliary Surgery Dept.1, Ningbo No.2 Hospital, Ningbo City, Zhejiang Province, China.

Förderung

  • Zhejiang Provincial Public Welfare Technology Program of China
  • Natural Science Fund of Ningbo
  • HwaMei Research Foundation of Ningbo No.2 Hospital
  • Ningbo Key Laboratory of Multimodal Intelligent Detection and Translational Research for Major Diseases
  • National Natural Science Foundation of China

Zitieren

APA

Ji, Y., Tuo, P., Ruan, C., Zhang, S., Wang, F., Shen, J., & Zhu, P. (2026). Harnessing metabolic dependence-driven antibiotic synergy to eradicate tolerant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 81(7). https://doi.org/10.1093/jac/dkag204

Vancouver

Ji Y, Tuo P, Ruan C, Zhang S, Wang F, Shen J, et al. Harnessing metabolic dependence-driven antibiotic synergy to eradicate tolerant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 2026;81(7). doi:10.1093/jac/dkag204

BibTeX
@article{Ji2026,
  author = {Ji, Yuanye and Tuo, Ping and Ruan, Chunyan and Zhang, Sijia and Wang, Fajiu and Shen, Jia and Zhu, Peng},
  title = {Harnessing metabolic dependence-driven antibiotic synergy to eradicate tolerant Pseudomonas aeruginosa},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {7},
  doi = {10.1093/jac/dkag204}
}
Kostenlos starten →